ILLUMINA, INC. (ILMN) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
51/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinILMN / S&P 42.65% / 15.20% |
LoseILMN / S&P 4.88% / 15.00% |
LoseILMN / S&P -32.15% / 50.40% |
| 2026-Q10/3 |
LoseILMN / S&P -6.02% / -4.33% |
LoseILMN / S&P 1.29% / 11.30% |
LoseILMN / S&P -190.61% / 27.70% |
| 2025-Q41/3 |
WinILMN / S&P 38.11% / 2.65% |
LoseILMN / S&P -0.66% / 9.00% |
LoseILMN / S&P -170.96% / 13.40% |
| 2025-Q30/3 |
LoseILMN / S&P -0.46% / 8.12% |
LoseILMN / S&P -2.32% / 4.61% |
LoseILMN / S&P -144.78% / 13.45% |
| 2025-Q21/3 |
WinILMN / S&P 20.25% / 10.94% |
LoseILMN / S&P -3.27% / 4.83% |
LoseILMN / S&P -141.25% / 10.63% |
| 2025-Q10/3 |
LoseILMN / S&P -40.63% / -4.27% |
LoseILMN / S&P -3.47% / 4.98% |
LoseILMN / S&P -25.52% / 10.57% |
| 2024-Q41/3 |
WinILMN / S&P 2.47% / 2.41% |
LoseILMN / S&P -2.93% / 5.25% |
LoseILMN / S&P 4.63% / 6.15% |
| 2024-Q32/3 |
WinILMN / S&P 24.94% / 5.89% |
LoseILMN / S&P -1.68% / 5.89% |
WinILMN / S&P 40.28% / 6.11% |
| 2024-Q20/3 |
LoseILMN / S&P -21.86% / 4.28% |
LoseILMN / S&P -0.72% / 5.38% |
LoseILMN / S&P -27.98% / 5.12% |
| 2024-Q10/3 |
LoseILMN / S&P -1.38% / 10.56% |
LoseILMN / S&P 1.03% / 5.71% |
LoseILMN / S&P -71.41% / 5.59% |
| 2023-Q40/3 |
LoseILMN / S&P 1.43% / 11.69% |
LoseILMN / S&P -1.72% / 6.81% |
LoseILMN / S&P -73.77% / 7.78% |
| 2023-Q30/3 |
LoseILMN / S&P -26.78% / -3.27% |
LoseILMN / S&P -4.98% / 7.52% |
LoseILMN / S&P -73.14% / -5.03% |
| 2023-Q21/3 |
LoseILMN / S&P -19.38% / 8.74% |
LoseILMN / S&P -4.92% / 9.50% |
WinILMN / S&P 29444.44% / -8.57% |
| 2023-Q11/3 |
WinILMN / S&P 15.01% / 7.50% |
LoseILMN / S&P -4.49% / 10.77% |
LoseILMN / S&P -723.85% / -15.69% |
| 2022-Q40/3 |
LoseILMN / S&P 5.98% / 7.56% |
LoseILMN / S&P 1.26% / 11.88% |
LoseILMN / S&P -657.37% / -17.99% |
| 2022-Q31/3 |
WinILMN / S&P 3.49% / -4.88% |
LoseILMN / S&P 9.79% / 13.47% |
LoseILMN / S&P -533.99% / -1.41% |
| 2022-Q21/3 |
LoseILMN / S&P -47.24% / -16.10% |
WinILMN / S&P 18.31% / 13.71% |
LoseILMN / S&P -101.72% / 11.04% |
| 2022-Q11/3 |
LoseILMN / S&P -8.16% / -4.60% |
WinILMN / S&P 34.06% / 15.97% |
LoseILMN / S&P 6.78% / 42.23% |
| 2021-Q41/3 |
LoseILMN / S&P -6.21% / 11.03% |
WinILMN / S&P 39.73% / 15.00% |
LoseILMN / S&P 12.81% / 96.40% |
| 2021-Q31/3 |
LoseILMN / S&P -14.29% / 0.58% |
WinILMN / S&P 32.18% / 10.77% |
LoseILMN / S&P 41.30% / 69.42% |
| 2021-Q22/3 |
WinILMN / S&P 23.21% / 8.55% |
WinILMN / S&P 18.35% / 6.58% |
LoseILMN / S&P 11.54% / 51.81% |
| 2021-Q10/3 |
LoseILMN / S&P 3.80% / 6.17% |
LoseILMN / S&P -2.33% / -1.06% |
LoseILMN / S&P -32.60% / 7.39% |
| 2020-Q41/3 |
WinILMN / S&P 19.71% / 12.15% |
LoseILMN / S&P -8.58% / -3.72% |
LoseILMN / S&P -34.07% / -33.42% |
| 2020-Q30/3 |
LoseILMN / S&P -16.54% / 8.93% |
LoseILMN / S&P -6.36% / -2.04% |
LoseILMN / S&P -34.20% / -27.10% |
| 2020-Q22/3 |
WinILMN / S&P 35.60% / 20.54% |
LoseILMN / S&P -1.56% / -0.46% |
WinILMN / S&P -25.71% / -27.11% |
| 2020-Q13/3 |
WinILMN / S&P -17.67% / -19.60% |
WinILMN / S&P 4.71% / 3.47% |
WinILMN / S&P 11.01% / -14.75% |
| 2019-Q42/3 |
LoseILMN / S&P 9.05% / 9.07% |
WinILMN / S&P 6.33% / 5.36% |
WinILMN / S&P 21.40% / 2.99% |
| 2019-Q32/3 |
LoseILMN / S&P -17.37% / 1.70% |
WinILMN / S&P 6.66% / 5.02% |
WinILMN / S&P 41.77% / 0.21% |
| 2019-Q23/3 |
WinILMN / S&P 18.49% / 4.30% |
WinILMN / S&P 9.70% / 6.64% |
WinILMN / S&P 43.18% / 8.65% |
| 2019-Q12/3 |
LoseILMN / S&P 3.59% / 13.65% |
WinILMN / S&P 15.71% / 8.12% |
WinILMN / S&P 48.19% / 14.29% |
| 2018-Q41/3 |
LoseILMN / S&P -18.29% / -13.52% |
WinILMN / S&P 21.12% / 9.05% |
LoseILMN / S&P 12.78% / 18.23% |
| 2018-Q32/3 |
WinILMN / S&P 31.43% / 7.71% |
WinILMN / S&P 25.03% / 10.21% |
LoseILMN / S&P -12.17% / 19.06% |
| 2018-Q22/3 |
WinILMN / S&P 18.13% / 3.43% |
WinILMN / S&P 24.82% / 9.03% |
LoseILMN / S&P -12.35% / 14.46% |
| 2018-Q12/3 |
WinILMN / S&P 8.21% / -0.76% |
WinILMN / S&P 21.08% / 7.68% |
LoseILMN / S&P -22.33% / 12.46% |
| 2017-Q43/3 |
WinILMN / S&P 9.68% / 6.64% |
WinILMN / S&P 14.72% / 7.03% |
WinILMN / S&P 59.55% / 13.82% |
| 2017-Q33/3 |
WinILMN / S&P 14.80% / 4.48% |
WinILMN / S&P 9.37% / 5.68% |
WinILMN / S&P 75.33% / 17.57% |
| 2017-Q22/3 |
LoseILMN / S&P 1.69% / 3.09% |
WinILMN / S&P 7.43% / 4.83% |
WinILMN / S&P 71.92% / 17.74% |
| 2017-Q13/3 |
WinILMN / S&P 33.27% / 6.07% |
WinILMN / S&P 7.57% / 3.67% |
WinILMN / S&P 78.14% / 13.32% |
| 2016-Q41/3 |
LoseILMN / S&P -29.52% / 3.82% |
WinILMN / S&P 8.02% / 2.09% |
LoseILMN / S&P -0.64% / 7.05% |
| 2016-Q32/3 |
WinILMN / S&P 29.41% / 3.85% |
WinILMN / S&P 10.75% / 0.20% |
LoseILMN / S&P -12.54% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ILMN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 127.78% | 20.78% |
| Annualized return | 127.78% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ILMN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -49.45% | 83.14% |
| Annualized return | -12.75% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | ILMN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 38.86% | 319.30% |
| Annualized return | 3.34% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |